115 related articles for article (PubMed ID: 6281603)
1. Hypercalcemia in association with a Leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man.
Berger ME; Golub MS; Sowers JR; Brickman AS; Nyby M; Troyer H; Rude RK; Singer FR; Horst R; Deftos LJ
Life Sci; 1982 May; 30(18):1509-15. PubMed ID: 6281603
[TBL] [Abstract][Full Text] [Related]
2. Humoral hypercalcemia caused by a rat Leydig-cell tumor is associated with suppressed parathyroid hormone secretion and increased urinary cAMP excretion.
Spiegel AM; Saxe AW; Deftos LJ; Brennan MF
Horm Metab Res; 1983 Jun; 15(6):299-304. PubMed ID: 6307850
[TBL] [Abstract][Full Text] [Related]
3. Humoral hypercalcemia of malignancy: a syndrome in search of a hormone.
Gottleib S; Rude RK; Sharp CF; Singer FR
Am J Med; 1982 Nov; 73(5):751-5. PubMed ID: 6291389
[TBL] [Abstract][Full Text] [Related]
4. Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.
Hirschel-Scholz S; Caverzasio J; Rizzoli R; Bonjour JP
J Clin Invest; 1986 Jul; 78(1):319-22. PubMed ID: 3013941
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia in dogs with lymphosarcoma. Biochemical, ultrastructural, and histomorphometric investigations.
Meuten DJ; Kociba GJ; Capen CC; Chew DJ; Segre GV; Levine L; Tashjian AH; Voelkel EF; Nagode LA
Lab Invest; 1983 Nov; 49(5):553-62. PubMed ID: 6314038
[TBL] [Abstract][Full Text] [Related]
6. Effects of passive immunization against parathyroid hormone (PTH)-like peptide and PTH in hypercalcemic tumor-bearing rats and normocalcemic controls.
Henderson J; Bernier S; D'Amour P; Goltzman D
Endocrinology; 1990 Sep; 127(3):1310-8. PubMed ID: 2167215
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy.
Insogna KL; Stewart AF; Vignery AM; Weir EC; Namnum PA; Baron RE; Kirkwood JM; Deftos LM; Broadus AE
Endocrinology; 1984 Mar; 114(3):888-96. PubMed ID: 6546543
[TBL] [Abstract][Full Text] [Related]
8. The effects of dichloromethylene diphosphonate on hypercalcemia and other parameters of the humoral hypercalcemia of malignancy in the rat Leydig cell tumor.
Martodam RR; Thornton KS; Sica DA; D'Souza SM; Flora L; Mundy GR
Calcif Tissue Int; 1983 Jul; 35(4-5):512-9. PubMed ID: 6311375
[No Abstract] [Full Text] [Related]
9. Measurement of circulating parathyroid hormone-related protein in rats with humoral hypercalcemia of malignancy using a two-site immunoradiometric assay.
Gaich G; Burtis WJ
Endocrinology; 1990 Sep; 127(3):1444-9. PubMed ID: 2387260
[TBL] [Abstract][Full Text] [Related]
10. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
Brown GM; Morris CA; Mitnick MA; Insogna KL
J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
[TBL] [Abstract][Full Text] [Related]
11. Morphologic and functional studies of a rat hypercalcemia-associated testicular tumor maintained in cell culture.
Saxe AW; Santora A; Norton J; Triche T; Brennan MF; Spiegel A
Surgery; 1985 Dec; 98(6):1013-23. PubMed ID: 3000012
[TBL] [Abstract][Full Text] [Related]
12. A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy.
Brenner DE; Harvey HA; Lipton A; Demers L
Cancer; 1982 Feb; 49(3):556-61. PubMed ID: 7059914
[TBL] [Abstract][Full Text] [Related]
13. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
Haq M; Kremer R; Goltzman D; Rabbani SA
J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone-like changes in renal calcium and phosphate reabsorption induced by Leydig cell tumor in thyroparathyroidectomized rats.
Rizzoli R; Caverzasio J; Fleisch H; Bonjour JP
Endocrinology; 1986 Sep; 119(3):1004-9. PubMed ID: 3755393
[TBL] [Abstract][Full Text] [Related]
15. The hypercalcemic rat Leydig cell tumor--a model of the humoral hypercalcemia of malignancy.
Sica DA; Martodam RR; Aronow J; Mundy GR
Calcif Tissue Int; 1983 May; 35(3):287-93. PubMed ID: 6871760
[No Abstract] [Full Text] [Related]
16. Hypercalcemia and neoplasia. Biologic, biochemical, and ultrastructural studies of a hypercalcemia-producing Leydig cell tumor of the rat.
Rice BF; Roth LM; Cole FE; MacPhee AA; Davis K; Ponthier RL; Sternberg WH
Lab Invest; 1975 Oct; 33(4):428-39. PubMed ID: 52757
[TBL] [Abstract][Full Text] [Related]
17. Evidence of a probable role for 25-hydroxyvitamin D in the regulation of human calcium metabolism.
Bell NH; Epstein S; Shary J; Greene V; Oexmann MJ; Shaw S
J Bone Miner Res; 1988 Oct; 3(5):489-95. PubMed ID: 2848397
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of hypercalcemia in nude mice bearing a human renal carcinoma.
Strewler GJ; Wronski TJ; Halloran BP; Miller SC; Leung SC; Williams RD; Nissenson RA
Endocrinology; 1986 Jul; 119(1):303-10. PubMed ID: 3013591
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of resistance to the phosphaturic effect of the parathyroid hormone in the hamster.
Knox FG; Preiss J; Kim JK; Dousa TP
J Clin Invest; 1977 Apr; 59(4):675-83. PubMed ID: 14974
[TBL] [Abstract][Full Text] [Related]
20. [Humoral mechanisms in neoplastic hypercalcemia].
Gennari C; Montagnani M; Nami R; Francini G
Minerva Med; 1984 Feb; 75(6):235-9. PubMed ID: 6324038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
